|The Canine ACTN4 actn4 (Catalog #MBS7246064) is an ELISA Kit and is intended for research purposes only. The product is available for immediate purchase. The MBS7246064 ELISA Kit recognizes Canine (Dog, General) ACTN4.
The ACTN4 actn4 product has the following accession number(s) (GI #12025678) (NCBI Accession #NP_004915.2). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
(Or you can also download the PDF Manual
for complete product instructions).
Samples: Serum, plasma, Cell Culture Supernatants, body fluid and tissue homogenate. Canine alpha-actinin-4 (ACTN-4) ELISA Kit or ELISA (enzyme-linked immunosorbant assays) Kits in general, are a valuable research tool for a myriad of applications in a range of scientific settings. Currently, three major types of ELISA formats are used by researchers: sandwich, competitive and indirect. Most commercially available ELISA Kits are sandwich or competitive. Commercially available ELISA Kits contain wells that have been pre-coated with the capture antibody. Please refer to the product manual for the ELISA format of your specific kit. Adenocarcinoma, Carcinoma, Disease Models, Animal, Glomerulosclerosis, Focal Segmental, Hypertension, Inflammation, Kidney Diseases, Lung Neoplasms, Neoplasm Metastasis, Proteinuria are some of the diseases may be linked to Canine alpha-actinin-4 (ACTN-4) ELISA Kit. The following patways have been known to be associated with this gene. ACTN4 also interacts with the following gene(s): ITGB1, KIRREL, PDLIM2, SERPINE1. Blood, Bone, Heart, Kidney, Lung, Lymph, Lymph Node, Nerve, Skin, Vascular tissues are correlated with this protein.